JP2001522835A5 - - Google Patents

Download PDF

Info

Publication number
JP2001522835A5
JP2001522835A5 JP2000520419A JP2000520419A JP2001522835A5 JP 2001522835 A5 JP2001522835 A5 JP 2001522835A5 JP 2000520419 A JP2000520419 A JP 2000520419A JP 2000520419 A JP2000520419 A JP 2000520419A JP 2001522835 A5 JP2001522835 A5 JP 2001522835A5
Authority
JP
Japan
Prior art keywords
compound
descarboethoxyloratadine
fexofenadine
loratadine
cetirizine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000520419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001522835A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/023223 external-priority patent/WO1999024405A1/en
Publication of JP2001522835A publication Critical patent/JP2001522835A/ja
Publication of JP2001522835A5 publication Critical patent/JP2001522835A5/ja
Ceased legal-status Critical Current

Links

JP2000520419A 1997-11-07 1998-11-05 フェニル−アルキル−イミダゾール型のh3レセプターリガンド Ceased JP2001522835A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96634497A 1997-11-07 1997-11-07
US08/966,344 1997-11-07
US12971198A 1998-08-05 1998-08-05
US09/129,711 1998-08-05
PCT/US1998/023223 WO1999024405A1 (en) 1997-11-07 1998-11-05 H3 receptor ligands of the phenyl-alkyl-imidazoles type

Publications (2)

Publication Number Publication Date
JP2001522835A JP2001522835A (ja) 2001-11-20
JP2001522835A5 true JP2001522835A5 (https=) 2006-01-05

Family

ID=26827847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520419A Ceased JP2001522835A (ja) 1997-11-07 1998-11-05 フェニル−アルキル−イミダゾール型のh3レセプターリガンド

Country Status (17)

Country Link
EP (1) EP1028947B8 (https=)
JP (1) JP2001522835A (https=)
KR (1) KR20010031724A (https=)
CN (1) CN1130349C (https=)
AR (1) AR016672A1 (https=)
AT (1) ATE219062T1 (https=)
AU (1) AU1296699A (https=)
CA (1) CA2308586A1 (https=)
CO (1) CO5011065A1 (https=)
DE (1) DE69806042T2 (https=)
ES (1) ES2174510T3 (https=)
HU (1) HUP0004292A3 (https=)
IL (1) IL135729A0 (https=)
NZ (1) NZ504124A (https=)
PE (1) PE134399A1 (https=)
TW (1) TW421645B (https=)
WO (1) WO1999024405A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
MXPA03008356A (es) 2001-03-13 2003-12-11 Schering Corp Compuestos del tipo no imidazol como antagonistas de histamina h3.
KR20050071598A (ko) * 2002-10-24 2005-07-07 메르크 파텐트 게엠베하 라프-키나아제 억제제로서의 메틸렌 우레아 유도체
AU2006204724A1 (en) 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
EP1749523A1 (en) * 2005-07-29 2007-02-07 Neuropharma, S.A. GSK-3 inhibitors
WO2007035703A1 (en) 2005-09-20 2007-03-29 Schering Corporation 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
US20150225369A1 (en) * 2012-08-29 2015-08-13 Merck Patent Gmbh Ddr2 inhibitors for the treatment of osteoarthritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
JPH09505298A (ja) * 1993-11-15 1997-05-27 シェーリング コーポレイション H▲下3▼‐レセプターアンタゴニストとしてのフェニル‐アルキルイミダゾール
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
KR20000029975A (ko) * 1996-08-16 2000-05-25 둘락 노먼 씨. 히스타민수용체길항제의배합물을사용한상부기도알레르기반응의치료

Similar Documents

Publication Publication Date Title
BR0017025A (pt) Antagonistas do receptor y5 do neuropeptìdeo y de imidazola substituìda
EP1223938A4 (en) TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF COMPOUNDS OF 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONISTS / ALPHA-2 ADRENOZEPTORANTAGONISTS
GEP20105025B (en) Pharmaceutical compositions for treatent of atherosclerosis and related conditions and use thereof for treatment of these diseases
EP1882686A3 (en) Pyrrolidine and piperidine derivates as nk1 antagonists
RU96119781A (ru) Применение 2-фенил-3-ароилбензотиофенов для снижения уровня холестерина в сыворотке, фармацевтическая композиция
JP2005531488A5 (https=)
IS5539A (is) 4-(2-ketó-1-bensímidazólinýl) píperidín efnasambönd sem mótlyf fyrir orl 1-viðtaka
MY130803A (en) New quinuclidine amide derivatives
IS7276A (is) Lyfjafræðileg nanóagna samsetning takykínín viðtakamótlyfs
HK1054333A1 (zh) 杂芳基脲神经肽yy5受体拮抗剂
WO2002076925A3 (en) Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
EP1772142A3 (en) Organic compounds
MXPA03009644A (es) Grupos azabiciclicos sustituidos para el tratamiento de enfermedades.
NZ593444A (en) 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2001518509A5 (https=)
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
JP2003529596A5 (https=)
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
JP2002519425A5 (https=)
SG154443A1 (en) Piperidine derivatives as nk1 antagonists
DE60322680D1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
ATE352543T1 (de) Ein dioxino(2,3-g)chinolin-9-carbonsäure derivat als nk3 rezeptor antagonist
JP2001522835A5 (https=)